Urquhart BL - Search Results

1

The effect of mesna on plasma total homocysteine concentration in hemodialysis patients.

Urquhart BL, Freeman DJ, Spence JD, House AA. Urquhart BL, et al. Am J Kidney Dis. 2007 Jan;49(1):109-17. doi: 10.1053/j.ajkd.2006.10.002. Am J Kidney Dis. 2007. PMID: 17185151

2

Monitoring clozapine: are fingerprick blood and plasma clozapine levels equivalent to arm venipuncture blood and plasma levels?

Goossen RB, Freeman DJ, Satchell AM, Urquhart BL. Goossen RB, et al. Among authors: urquhart bl. Ther Drug Monit. 2003 Aug;25(4):469-72. doi: 10.1097/00007691-200308000-00009. Ther Drug Monit. 2003. PMID: 12883231

3

Dimercaptosuccinic acid for the treatment of hyperhomocysteinemia in hemodialysis patients: a placebo-controlled, double-blind, randomized trial.

House AA, Eliasziw M, Urquhart BL, Freeman DJ, Spence JD. House AA, et al. Among authors: urquhart bl. Am J Kidney Dis. 2004 Oct;44(4):689-94. Am J Kidney Dis. 2004. PMID: 15384020 Clinical Trial.

4

Thiol exchange: an in vitro assay that predicts the efficacy of novel homocysteine lowering therapies.

Urquhart BL, House AA, Cutler MJ, Spence JD, Freeman DJ. Urquhart BL, et al. J Pharm Sci. 2006 Aug;95(8):1742-50. doi: 10.1002/jps.20680. J Pharm Sci. 2006. PMID: 16795014

5

Reinstalling antitumor immunity by inhibiting tumor-derived immunosuppressive molecule IDO through RNA interference.

Zheng X, Koropatnick J, Li M, Zhang X, Ling F, Ren X, Hao X, Sun H, Vladau C, Franek JA, Feng B, Urquhart BL, Zhong R, Freeman DJ, Garcia B, Min WP. Zheng X, et al. Among authors: urquhart bl. J Immunol. 2006 Oct 15;177(8):5639-46. doi: 10.4049/jimmunol.177.8.5639. J Immunol. 2006. PMID: 17015752

6

Mesna as a nonvitamin intervention to lower plasma total homocysteine concentration: implications for assessment of the homocysteine theory of atherosclerosis.

Urquhart BL, Freeman DJ, Spence JD, House AA. Urquhart BL, et al. J Clin Pharmacol. 2007 Aug;47(8):991-7. doi: 10.1177/0091270007303767. Epub 2007 Jul 5. J Clin Pharmacol. 2007. PMID: 17615252 Clinical Trial.

7

Assessing plasma total homocysteine in patients with end-stage renal disease.

Urquhart BL, House AA. Urquhart BL, et al. Perit Dial Int. 2007 Sep-Oct;27(5):476-88. Perit Dial Int. 2007. PMID: 17704433 Review.

8

Mesna for treatment of hyperhomocysteinemia in hemodialysis patients: a placebo-controlled, double-blind, randomized trial.

Urquhart BL, Freeman DJ, Cutler MJ, Mainra R, Spence JD, House AA. Urquhart BL, et al. Clin J Am Soc Nephrol. 2008 Jul;3(4):1041-7. doi: 10.2215/CJN.04771107. Epub 2008 Mar 12. Clin J Am Soc Nephrol. 2008. PMID: 18337551 Free PMC article. Clinical Trial.

9

Mesna for the treatment of hyperhomocysteinemia in hemodialysis patients.

Cutler MJ, Urquhart BL, Freeman DJ, Spence JD, House AA. Cutler MJ, et al. Among authors: urquhart bl. Blood Purif. 2009;27(3):306-10. doi: 10.1159/000207197. Epub 2009 Mar 9. Blood Purif. 2009. PMID: 19270449 Clinical Trial.

10

ECG machine QTc intervals are inaccurate in hemodialysis patients.

Thomson BK, Momciu B, Huang SH, Chan CT, Urquhart B, Skanes A, Krahn A, Klein G, Lindsay RM. Thomson BK, et al. Nephron Clin Pract. 2013;124(1-2):113-8. doi: 10.1159/000355862. Epub 2013 Nov 2. Nephron Clin Pract. 2013. PMID: 24192796

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

79 results

Search Page